Visit healthcare professional site

Request BLC locations near you

Click here

Request BLC locations near you

Click here

Privacy policy

This Privacy Policy contains information about how Photocure processes your personal data when you use our website or when you contact us. We advise you to read our Privacy Policy carefully before agreeing to our processing of your personal data.

 

Key Concepts

Personal data is information that can be used independently, or together with other information, to identify, localize or contact an individual. Examples of personal data include name, phone number and IP address.

Processing of personal data includes all types of personal data handling, e.g.: collection, analysis, registration and storing. The so-called “Personal Data Controller" determines the purpose of the processing of personal data and decides what personal data will be requested. The Personal Data Controller has the ultimate responsibility for your personal data to be processed in accordance with applicable data protection laws.

Photocure is the Personal Data Controller

Related to this website and when contacting us, Photocure is the Personal Data Controller.

How can we access your data?

When you interact with us digitally via newsletter, by visiting our website or by contacting us via email or phone, you may submit personal data.

What are cookies?

Cookies are a standard technology used today by most websites, including Photocure’s website. A cookie is a small amount of text stored by your browser when you visit a website. It captures and stores data that can be used in conjunction with statistics to make webpages better, to measure and improve advertising relevance, and to remember when you log into webpages or when you share information in social media.

Most modern browsers (Google Chrome, Firefox, Edge, Internet Explorer, Safari, Opera, etc.) are set to accept cookies automatically, but you can choose to change your settings so your computer does not accept cookies. Please note that if you do not accept cookies, many websites will not work optimally. https://support.microsoft.com/en-us/help/17442/windows-internet-explorer-delete-manage-cookies

Cookies at Photocure.com
ASP.NET_SessionId
This is a cookie that is used to identify the user’s session on the server. The session is an area on the server that can be used to store data in between http requests. The sessionId cookie expires when you close your browser.

Cookies from Google Analytics:
_utmz: Shows where you came from (search engine, keywords, link etc.) when landing on our pages. We use Google Analytics internally on our webpages and in banners and pictures. That’s why you can see cookies named __utmz.
__utma: Keeps track of how many times you have visited our webpages. This is because we want to keep track of how many first-time and frequent visitors we have to our pages.
__utmb og __utmc: Keeps track of how long you stay on the webpage. This is deleted when you leave the webpage.

How do we use your personal data?

The data you have submitted can be used for the following purposes:

  • to send you email/enewsletters
  • to obtain statistics and information regarding user behavior to improve our website and the corresponding user experience
  • to communicate with you following your initial contact

Consent to mail correspondence, direct marketing and continued communication

By agreeing to our processing of your personal data for the purposes stated above, you agree:

  • that we process your personal data in accordance with this Privacy Policy
  • that we can contact you regarding your communication with us
  • that we will only keep your CV or application letter when we are in a hiring process
  • that we will subscribe you to the types of mailings you have chosen yourself and accepted

You can update your subscription settings and unsubscribe to further mailings

For how long is the data kept?

We only process personal data for as long as it takes to fulfil the purpose of their collection. Depending on the data we have collected it may vary how long they will be kept.

Who can access the data?

Submitted data are available to a limited number of people within the company.

We share certain data within the context of third-party cooperation

We do not sell your personal data to any third party. In the event there is an ongoing dialogue between you, us, and any of our business partners, we may need to share the personal data.

Where is the data stored?

The data are stored in various systems. It depends on the personal data provided.

Data transfers made to third-country servers comply with the secure data transfer rules under the General Data Protection Regulation, GDPR, or are made under the Privacy Shield Frameworks developed between the EU and USA. More information about Privacy Shield Frameworks is available on this page: https://www.privacyshield.gov

You are entitled to know what data we have about you

The new data protection regulation entitles you to request a registry extract on the data we have about you. You may also request that we correct incorrect data or delete data about you. Further, you are entitled to withdraw your consent to our processing of your personal data. If you withdraw your consent, we will delete the data we have about you.

Exception to this is where we are required by law to report your data to authorities. In that case, your personal data will be anonymized. Please note that deletion of your personal data stored by us may impact the delivery of information in the context of a customer relationship, as well as potentially impact any ongoing dialogues.

If you wish to withdraw your consent, or request a registry extract, correction or deletion, please contact us via email.

Contact details to Photocure

Related to this website and when contacting us, Photocure is the Personal Data Controller and is responsible for the processing of your personal data. If you have questions regarding our processing or wish to get in touch with us to exercise your rights, please find our contact details below:
Photocure ASA
Hoffsveien 4
0275 Oslo
Norway
email address: [email protected]
Phone: +47 22 06 22 10
Fax: +47 22 06 22 18

United States
Photocure Inc.
202 Carnegie Center, #101
Princeton, NJ 08540
USA
email address: [email protected]
Phone: +1 609 759 6500
Fax: +1 609 799 0816

Important safety information about Cysview® (hexaminolevulinate HCI)

Important safety information about Cysview® (hexaminolevulinate HCI)

Cysview is an optical imaging agent used to detect non-muscle invasive bladder cancer in patients suspected or known to have lesion(s) on the basis of a prior cystoscopy, or in patients undergoing surveillance cystoscopy for bladder cancer. Cysview is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer.

Important Risk & Safety Information for Cysview® (hexaminolevulinate HCl)

Cysview is an optical imaging agent used to detect non-muscle invasive bladder cancer in patients suspected or known to have lesion(s) on the basis of a prior cystoscopy, or in patients undergoing surveillance cystoscopy for bladder cancer. Cysview is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer. False-positive fluorescence may occur due to inflammation, trauma from past cystoscopies, scar tissue, previous bladder biopsy, and recent Bacillus Calmette-Guérin (BCG) therapy or intravesical chemotherapy.

Anaphylactoid shock, hypersensitivity reactions, bladder pain, bladder inflammation (cystitis), and abnormal urine tests have been reported after administration of Cysview. The most common adverse reactions seen in clinical trials were bladder spasm, trouble urinating, discomfort when urinating, frequent urination, blood in the urine, and bladder pain.

Cysview should not be used in patients with large amounts of blood in their urine, any known allergy to Cysview or any derivative of aminolevulinic acid, or porphyria, a condition that means you already have high levels of porphyrins in your body. No specific drug interaction studies have been performed.

There are no available data on Cysview use in pediatric patients, pregnant women, or nursing mothers.

BLC® and Cysview® are
registered trademarks of Photocure ASA

X-twitter Facebook-f

©2025 Photocure/Cysview. All Rights Reserved.

The information on this website is intended for U.S audiences only.
Residents of Canada, please visit Cysview.ca.

Scroll to Top
Are you a Healthcare Professional?
Yes, I am a U.S Healthcare Professional
No, I am not a U.S Healthcare Professional

You are now leaving the Cysview.com website.

Photocure offers links to third-party websites that may be of interest to our website visitors. If you continue, you will leave the Cysview.com website and be directed to another site. These third-party sites are not under the control of Photocure, and Photocure is not responsible for and has no control over the content of linked third-party websites. Photocure makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any information contained in such websites. Photocure shall not be liable for any damages or injuries of any kind arising from such content or information or reliance thereon. Inclusion of any third-party link on the websites, the content, and/or the services does not imply an endorsement or recommendation by Photocure. You should take precautions when downloading files from all websites to protect your computer from viruses and other destructive programs. If you decide to access linked third-party websites, you do so at your own risk.

 

Please be aware that the security and privacy policies on the third-party sites may be different than Photocure’s policies, so please read third-party privacy and security policies closely. When you visit a third-party site, you will be subject to its terms and policies and no longer be protected by the Cysview.com privacy policy or security practices.

By clicking on the CONTINUE button below, you acknowledge the above statement and will be taken to the linked site. If you want to remain on Cysview.com, select the CANCEL button.

cancel
continue

You are now leaving the Cysview.com website.

Photocure offers links to third-party websites that may be of interest to our website visitors. If you continue, you will leave the Cysview.com website and be directed to another site. These third-party sites are not under the control of Photocure, and Photocure is not responsible for and has no control over the content of linked third-party websites. Photocure makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any information contained in such websites. Photocure shall not be liable for any damages or injuries of any kind arising from such content or information or reliance thereon. Inclusion of any third-party link on the websites, the content, and/or the services does not imply an endorsement or recommendation by Photocure. You should take precautions when downloading files from all websites to protect your computer from viruses and other destructive programs. If you decide to access linked third-party websites, you do so at your own risk.

 

Please be aware that the security and privacy policies on the third-party sites may be different than Photocure’s policies, so please read third-party privacy and security policies closely. When you visit a third-party site, you will be subject to its terms and policies and no longer be protected by the Cysview.com privacy policy or security practices.

By clicking on the CONTINUE button below, you acknowledge the above statement and will be taken to the linked site. If you want to remain on Cysview.com, select the CANCEL button.

cancel
continue

Bacillus Calmette-Guérin (BCG) is an immunotherapy that is put into the bladder directly to treat early-stage bladder cancer (NMIBC).1

Immunotherapies work by causing the body’s immune system to attack the cancer cells.1

Reference: 1. American Cancer Society. Intravesical Therapy for Bladder Cancer. 2022. Available online. Accessed March 2024.

Not all bladder cancer is the same so to help identify it and decide the best treatment option, it is classified according to stage and grade.1

Stage is determined by how far the cancer has gone into the bladder wall and spread, with the stages as follows:1

T0: No tumor     
Ta: Papillary tumor without invading the bladder wall     
TIS (CIS): Carcinoma in situ (non-invasive flat high-grade (G3) cancer)     
T1: Tumor invades the connective tissue under the surface lining     
T2: Tumor invades the muscle layer     
T3: Tumor penetrates the bladder wall and invades the surrounding fat layer   
T4: Tumor invades other organs (i.e., prostate, uterus, vagina, pelvic wall)

Grade is expressed as a number between 1 (low) and 3 (high, i.e., G3); the higher the number, the more the tumor is abnormal. Your urologist, however, may refer to the tumor as either low grade or high grade instead of using a number.1

Reference: 1. Bladder Cancer Advocacy Network. Bladder Cancer Types, Stages and Grades. Available online. Accessed March 2024.

Bladder cancer is classified into two types, depending on the depth of invasion in the bladder wall:1
  • Non-muscle invasive bladder cancer (NMIBC) is in the inner layer of cells and has not gone deeper.1 These cancers are the most common (around 75% of all bladder cancer cases).2
  • Muscle-invasive bladder cancer is when the cancer has penetrated deeper layers of the bladder wall. These cancers are harder to treat and are more likely to spread to other organs.1

    • References: 1. American Cancer Society. What is Bladder Cancer? 2022. Available online. Accessed March 2024. 2. Babjuk M, Burger M, Capoun O, et al. European Association of Urology Guidelines on Non-Muscle-Invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2022;81(1):75–94.

    TURBT is a surgical procedure where a urologic oncologist removes tumors from the bladder wall. The procedure is performed under general anesthesia in the operating room.1

    Reference: 1. American Cancer Society. Bladder Cancer Surgery. 2019. Available online. Accessed March 2024.